Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

WATCHMAN FLX Pro European Registry

NCT: NCT07262255 · RECRUITING

NCT IDNCT07262255
StatusRECRUITING
Start Date2025-12-17
Completion2028-09

Brief Summary

The WATCHMAN FLX Pro European registry is intended to gather real world clinical data for patients undergoing left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro device. In a subregistry with approximately 300 patients, it is intended to use the VersaCross Connect™ LAAC Access Solution.

Frequently Asked Questions

What is WATCHMAN FLX Pro European Registry?

WATCHMAN FLX Pro European Registry is a clinical trial registered under NCT07262255. Current status: RECRUITING.

What is the status of NCT07262255?

The current status of NCT07262255 (WATCHMAN FLX Pro European Registry) is: RECRUITING.

When did WATCHMAN FLX Pro European Registry start?

WATCHMAN FLX Pro European Registry started on 2025-12-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑